Valneva: investor day in New York

(CercleFinance.com) - Valneva is holding an investor day in New York today to present its key value drivers for the next 12 to 18 months.


CEO Thomas Lingelbach, CFO Peter Bühler, and other members of the management team will highlight opportunities related to the Pfizer-led Lyme disease vaccine candidate, as well as the development of its commercial vaccine portfolio.

The event will be hybrid, with presentations available online and two Q&A sessions.

"This is a pivotal time for Valneva as we approach the last tick season before the end of the Phase 3 trial of our Lyme disease vaccine," said Lingelbach.








Copyright (c) 2024 CercleFinance.com. All rights reserved.